Effects of DDIT4 in Methamphetamine-Induced Autophagy and Apoptosis in Dopaminergic Neurons

Area of Science:

• Neuroscience
• Molecular Biology
• Toxicology

Background:

• Methamphetamine (METH) is an illicit drug known to cause significant neurotoxicity, particularly affecting dopaminergic pathways.
• Autophagy and apoptosis are critical cellular processes implicated in neurodegeneration.
• The role of DNA damage-inducible transcript 4 (DDIT4) in METH-induced neurotoxicity remains largely unexplored.

Purpose of the Study:

• To investigate the involvement of DDIT4 in METH-induced autophagy and apoptosis in dopaminergic neurons.
• To explore the potential of DDIT4 as a therapeutic target for mitigating METH neurotoxicity.

Main Methods:

• Utilized rat catecholaminergic PC12 cells and human dopaminergic SH-SY5Y cells, as well as Sprague Dawley rats exposed to METH.
• Assessed DDIT4 protein expression, autophagy levels, and apoptosis markers (cleaved caspase-3, cleaved PARP) using Western blot and flow cytometry.
• Examined the effects of DDIT4 silencing via siRNA (in vitro) and lentivirus (in vivo) on METH-induced cellular changes.
• Employed fluorescence and electron microscopy to evaluate autophagy.

Main Results:

• METH exposure significantly increased DDIT4 expression, autophagy, and apoptosis in both cell lines and rat brain regions (hippocampus, prefrontal cortex, striatum).
• Inhibition of DDIT4 expression effectively reduced METH-induced autophagy and apoptosis in vitro and in vivo.
• These DDIT4-related effects were dose-dependent, with no significant impact observed at low METH concentrations (1 μM).

Conclusions:

• DDIT4 plays a crucial role in mediating METH-induced dopaminergic neuronal autophagy and apoptosis, particularly at higher METH doses.
• DDIT4 inhibition demonstrates therapeutic potential for treating high-dose METH-induced neurotoxicity.
• Targeting DDIT4 represents a promising strategy for developing novel interventions against METH-related neurological damage.